NASDAQ: VTRS
Viatris Inc Stock Ownership - Who owns Viatris?

Insider buying vs selling

Have Viatris Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Theodora MistrasChief Financial Officer2026-01-011,203$12.45
$14.98kSell
Theodora MistrasChief Financial Officer2026-01-0113,395$12.45
$166.77kSell
Goff Corinne LeChief Commercial Officer2025-09-117,032$10.25
$72.04kSell
Scott Andrew SmithChief Executive Officer2025-08-1222,000$9.99
$219.74kBuy
Scott Andrew SmithChief Executive Officer2025-05-1260,000$8.94
$536.28kBuy
Goff Corinne LeChief Commercial Officer2025-04-15855$7.48
$6.40kSell
Goff Corinne LeChief Commercial Officer2025-04-1519,023$7.48
$142.29kSell
Goff Corinne LeChief Commercial Officer2025-03-0416,276$9.37
$152.51kSell
Goff Corinne LeChief Commercial Officer2025-03-04521$9.37
$4.88kSell
Rajiv MalikDirector2025-03-0435,816$9.37
$335.60kSell

1 of 3

VTRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTRS insiders and whales buy or sell their stock.

VTRS Shareholders

What type of owners hold Viatris Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.00%138,179,864$2.06BInstitution
Laboratories Abbott11.79%135,750,000$2.03BInsider
Blackrock Inc7.54%86,824,817$1.30BInstitution
Price T Rowe Associates Inc6.87%79,079,870$1.18BInstitution
Davis Selected Advisers6.79%78,177,984$1.17BInstitution
Products Abbott5.45%62,782,018$937.34MInsider
State Street Corp4.80%55,310,153$825.78MInstitution
Dimensional Fund Advisors LP3.48%40,026,301$597.59MInstitution
Geode Capital Management LLC2.70%31,106,924$464.43MInstitution
Ameriprise Financial Inc2.33%26,845,389$400.80MInstitution

1 of 3

VTRS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTRS82.08%17.92%Net SellingNet Selling
NBIX71.19%28.81%Net SellingNet Selling
ELAN91.26%8.74%Net BuyingNet Buying
RGC0.11%0.00%
RDY12.76%0.00%

Viatris Stock Ownership FAQ

Who owns Viatris?

Viatris (NASDAQ: VTRS) is owned by 84.74% institutional shareholders, 18.50% Viatris insiders, and 0.00% retail investors. Laboratories Abbott is the largest individual Viatris shareholder, owning 135.75M shares representing 11.79% of the company. Laboratories Abbott's Viatris shares are currently valued at $2.03B.

If you're new to stock investing, here's how to buy Viatris stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.